The peptide regulatory landscape in 2026 is in active flux. After the FDA placed 19 popular peptides in Category 2 in late 2023, HHS Secretary RFK Jr. announced in February 2026 that BPC 157 Ligament: 1 Unsafe Truth Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its FDA Compliance for Peptide Therapy and BPC 157 Holt Law The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University